Ilika plc award share options under the long term incentive plan

Ilika plc

Ilika plc (LON:IKA), a pioneer in solid-state battery technology, has announced that on 7 February 2022 it granted nominal value options over 229,759 ordinary shares of 1p each in the Company to Executive Directors under the Long Term Incentive Plan 2018. Each award vests on the achievement of certain performance targets over a three-year period. The options granted represent in aggregate 0.15 per cent of the Company’s issued share capital.

In addition, on 7 February 2022, 20,000 nominal value options previously awarded under the Company’s bonus scheme have been exercised by Steve Boydell, CFO, and the Executive Directors sold 30,000 shares in aggregate, primarily to cover tax liabilities arising from options exercised under the Company’s bonus scheme in 2021 and 2022.

Details of grants issued under the Company’s Long Term Incentive Plan 2018, options exercised and Ordinary Shares sold by each Executive Director are set out in the tables below, together with the total number of Ordinary Shares each Executive Director holds under option and is interested in.

DirectorNumber of options grantedNumber of options exercisedTotal number of Options now heldPer cent. of issued share capital
Graeme Purdy153,5412,362,1131.50
Steve Boydell76,21820,000755,7230.48
DirectorOrdinary shares soldNumber of shares held post salePer cent. of issued share capital
Graeme Purdy15,000782,9270.50
Steve Boydell15,00058,3460.04

EMI option scheme

Following the vesting of options under Ilika’s EMI share option schemes, 52,500 options with an exercise price of 21p, together with 265,000 options with an exercise price of 18.2p, have been converted into Ordinary shares of 1p each. 

Accordingly, to satisfy options exercised under both the Company’s EMI share option schemes and bonus scheme, the Company has applied to the London Stock Exchange for 337,500 Ordinary Shares to be admitted to trading on AIM. It is expected that Admission will occur at 8.00am on 11 February 2022.

Total Voting Rights

Following Admission, the Ilika issued share capital will comprise 157,217,043 Ordinary Shares and may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA’s Disclosure Guidance and Transparency Rules. The Company does not hold any shares in treasury. 

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika takes solid-state battery message to major UK energy storage conference

Ilika will present its UK-developed quasi-solid-state cell technology at the Faraday Institution Conference 2026 in Nottingham, placing its Goliath programme within a major energy storage innovation forum.

Ilika Plc capital raise supports Stereax launch and Goliath progress, says Cavendish

Ilika’s latest Cavendish note highlights fresh funding to support Stereax commercialisation and Goliath development across medical, defence and e-bike markets.

Defence battery demand highlights a practical growth opportunity

Defence applications are increasing the need for safer, lighter and more reliable battery technology.

Ilika raises ÂŁ4.56m in oversubscribed placing and subscription

Ilika has conditionally raised approximately ÂŁ4.56 million through an oversubscribed placing and subscription, with proceeds to support the commercialisation of its Stereax and Goliath solid-state battery technologies.

Ilika launches Retail Offer to raise up to ÂŁ0.5 Million

Ilika has opened a UK retail offer via BookBuild to raise up to £0.5 million, alongside a £4.56 million placing and directors’ subscription. Proceeds will support the commercial rollout of Stereax technology and further development of the Goliath battery programme.

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Search